Accutar Biotechnology, Inc.

Accutar is NJ biotech company. Our pipeline includes AC0699, ph1 oral chimeric degrader for breast cancer (with fast track designation), selective CDK4 inhibitor in IND enabling, and a portfolio of clinical / precllinical stage degraders and inhibitors

Address

Cranbury
NJ
United States
Loading